Effect of vagues nerve stimulation on lumbopelvic pain with constipatio

Not Applicable

Conditions: Other chronic pain
Condition 1: lumbopelvic myofascial pain syndrome. Condition 2: chronic functional constipation.
Constipation
G89.29
K59.0

Registration Number: IRCT20221231056994N1

Lead Sponsor: niversity of social welfare and rehabilitation sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: Female

Target Recruitment: 46

Inclusion Criteria

Body mass index less than 30 kg/m2
Having at least two signs of the Rome IV criteria
The presence of trigger points in at least 3 muscles from the rectus abdominus, psoas major, iliacus, quadratus lumbarum, piriformis, obturator internus, hamstrings, tensor fascia lata, adductors, gluteus medius, gluteus minimus, gluteus maximus and coccygeus on each side using algometer
widespread pain index is equal to or greater than 7

Exclusion Criteria

Neurological diseases
Metabolic and endocrine diseases
Thyroid diseases
Infectious and inflammatory diseases
Myopathy diseases
Cardiovascular diseases
Systemic diseases such as scleroderma and lupus
Cognitive and psychotic diseases
Surgeries of the digestive system
Long-term use of corticosteroids
Addiction and alcohol consumption
Taking drugs that affect the autonomic system (such as cholinergic and anticholinergic drugs and alpha and beta blockers)
Pregnancy and menopause
History of malignancy
Hemorrhoid, fissure and grade 3 and 4 rectal prolapse diseases

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The complete spontaneous bowel movements per week. Timepoint: Before and after 10 sessions of treatment. Method of measurement: The number of times a person has bowel movements per week.

Secondary Outcome Measures

Name	Time	Method
Heart rate variability. Timepoint: Before and after 10 sessions of treatment. Method of measurement: PowerLab data acquisition.;Quality of Life scale. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Patient Assessment of Constipation Quality of Life questionnaire.;Beck anxiety level. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Beck Anxiety Inventory.;Pain pressure threshold. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Algometer.;Pain intensity. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Visual Analogue Scale.;Severity constipation. Timepoint: Before and after 10 sessions of treatment. Method of measurement: Wexner questionnaire.